pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
MUCUS RELIEF DM MAXIMUM STRENGTH
MUCUS RELIEF DM MAXIMUM STRENGTH (GUAIFENESIN AND DEXTROMETHORPHAN HBR)
AUROBINDO PHARMA
0 catalysts
Preclinical
MUL-001
Neurofibromatoses Type II
Mulberry Biotherapeutics Inc
0 catalysts
MULTIHANCE
MULTIHANCE (GADOBENATE DIMEGLUMINE)
BRACCO
0 catalysts
MULTIPLE ELECTROLYTES PH 5.5
MULTIPLE ELECTROLYTES PH 5.5 (SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE)
FRESENIUS KABI USA
0 catalysts
← prev
page 126 of 271
next →
131
Pain89
Neurology1
Phase 2
MVAmBN-396
Eastern Equine Encephalitis
Bavarian Nordic AS
0 catalysts
Phase 2
MVCCOV-1901
Coronavirus Disease 2019 (COVID-19)
Medigen Vaccine Biologics Corp
0 catalysts
Preclinical
MVP-0601
Malignant Pleural Mesothelioma
OncoVITA SAS
0 catalysts
Preclinical
MVREX-101
Wounds
Immvira Co Ltd
0 catalysts
Preclinical
MVREX-104
Androgenic Alopecia
Immvira Co Ltd
0 catalysts
Preclinical
MVREX-107
Pulmonary Fibrosis
Immvira Co Ltd
0 catalysts
Phase 2
MVRT-3011
Recurrent Head And Neck Squamous Cell Carcinoma
Immvira Co Ltd
0 catalysts
Phase 2
MVX-220
Angelman Syndrome
Mavrix Bio LLC
0 catalysts
Phase 2
MWTx-01
Polycythemia Vera
$IRONDisc Medicine, Inc.
0 catalysts
Preclinical
MX-0612
Obesity
Mesox Ltd
0 catalysts
Preclinical
MX-1604
Liver Cancer
Mesox Ltd
0 catalysts
Preclinical
MYCO-003
psilocybin
Post-Traumatic Stress Disorder (PTSD)
Noveris Health Sciences Inc
0 catalysts
Preclinical
MYCO-004
Smoking Cessation
Noveris Health Sciences Inc
0 catalysts
MYCOPHENOLATE SODIUM
MYCOPHENOLATE SODIUM (MYCOPHENOLATE SODIUM)
Aurobindo Pharma Ltd
0 catalysts
MYDAYIS
MYDAYIS (DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, AND AMPHETAMINE SULFATE)
TAKEDA PHARMS USA
0 catalysts
MYOVIEW
MYOVIEW (TETROFOSMIN)
MEDI-PHYSICS
0 catalysts
MYQORZO
MYQORZO (AFICAMTEN)
1 INDICATIONS AND USAGE MYQORZO is indicated for the treatment of adults with…
$CYTKCYTOKINETICS INC
0 catalysts
Phase 2
MZ-1866
Unspecified Genetic Disorders
Mahzi Therapeutics Inc
0 catalysts
Phase 2
MaaT-013
Graft Versus Host Disease (GVHD)
MaaT Pharma SA
0 catalysts
Phase 3
Maci
Articular Cartilage Defect
$VCELVericel Corp
0 catalysts
Preclinical
Marburg vaccine
Marburgvirus Infections (Marburg Hemorrhagic Fever)
$SNGXSOLIGENIX, INC.
0 catalysts
Marketed
Marcaine
Bupivacaine Hydrochloride + Epinephrine ((bupivacaine hydrochloride + epinephrine bitartrate))
Local Anesthetic Effect
$PFEPFIZER INC
0 catalysts
Marketed
Maxidex
Maxidex (dexamethasone)
Allergic Conjunctivitis
$HROWHARROW, INC.
0 catalysts
Marketed
Maxitrol
Dexamethasone + Neomycin Sulfate + Polymyxin B Sulfate Sandoz ((dexamethasone + neomycin sulfate + polymyxin B [INN]))
Anterior Segment Inflammation
Sandoz Inc
0 catalysts
Marketed
Maxzide
Maxzide ((hydrochlorothiazide [INN] + triamterene))
Hypokalemia
Aurobindo Pharma USA Inc
0 catalysts
Phase 1
Medchew Dronabinol
dronabinol
Chemotherapy Induced Nausea and Vomiting
$IXHLIncannex Healthcare Inc.
0 catalysts